Reimbursement

News and trends on diagnostics testing, insurance coverage, and reimbursement.

Interpace Diagnostics said that the test will now be covered for Cigna's roughly 15 million members nationwide.

The company announced positive coverage decisions from Palmetto GBA, 14 BCBS plans, and Aetna.

Starting Oct. 1, the insurer will require clinicians and labs who order genetic and molecular tests for their patients to first get approval. 

The deal with Aetna includes coverage for Interpace's ThyGenX oncogene panel and ThyraMir microRNA gene expression classifier.

The test is now covered by Premera Blue Cross, a regional health plan with more than 2 million members located primarily in Washington, Oregon, and Alaska.

Polygamy amplified a rare genetic disease in area near Arizona-Utah border, BBC Future reports.

Genetic ancestry testing led one woman to learn that her father and another baby boy had been switched at birth, the Washington Post reports.

Simple de-identification methods can protect information in a database from attackers, a new study suggests.

In Science this week: approach to visualize chromatin structure in nuclei, and more.